Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
The dialogue between Venugopal, MD, and Nabhan, MD, delves into unresolved challenges in treating chronic myeloid leukemia (CML). Venugopal emphasizes the need for targeted therapies in CML blast…
Lobular breast cancer presents unique challenges in detection and treatment due to its diffuse growth pattern and differences from ductal cancers. Liz O’Riordan, MD, shares her personal journey,…
Colon cancer is the third leading cause of cancer-related deaths in the U.S., but early detection saves lives. This video explains how colon cancer starts as slow-growing polyps…
In this insightful discussion on the Rena Malik MD podcast, Rena Malik, MD interviews Stacy Loeb, MD, a Professor of Urology at New York University. They explore the…
Christopher Patriquin, MD, Hematologist at Toronto General Hospital, discusses the challenges of diagnosing paroxysmal nocturnal hemoglobinuria (PNH) due to its varied symptoms, such as thrombosis, anemia, and unusual…
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease where red blood cells rupture due to the immune system mistakenly attacking them. This happens because of a mutation…
Antonio Risitano, MD, PhD, highlights exciting developments in treatments for paroxysmal nocturnal hemoglobinuria (PNH), specifically the introduction of complement inhibitors that have transformed the prognosis of the disease.…
The meeting discusses the effectiveness and value of treatments for paroxysmal nocturnal hemoglobinuria (PNH). During the session, individual members introduce themselves, disclose conflicts of interest, and emphasize patient…
Physicians at Sanjay Gandhi Postgraduate Institute of Medical Sciences successfully managed a pregnancy in a patient with Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. Despite the high…
This session focused on patient-reported outcomes for Paroxysmal Nocturnal Hemoglobinuria (PNH) and how the disease and current treatments affect patient lives. A key highlight was a Ukrainian patient’s…
